Chordia Therapeutics Inc. (TYO:190A)
Japan · Delayed Price · Currency is JPY 60.00
-1.00 (-1.64%)
Oct 6, 2026, 3:30 PM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 4.71 billion as of October 6, 2026. Its market cap has decreased by -46.63% in one year.
Market Cap
4.71B
Enterprise Value
2.21B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
60.00
ChartMarket Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 4.71B, a decrease of -62.55%. That is a compound annual growth rate of -34.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 4.71B | -36.75% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
| Jun 14, 2024 | 12.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyfuse Biomedical K.K. | 6.53B |
| CellSource | 6.23B |
| TMS Co., Ltd. | 5.75B |
| Soiken Holdings | 5.62B |
| PRISM BioLab Co.,LTD | 5.40B |
| Noile-Immune Biotech | 5.08B |
| Ribomic | 4.30B |
| D. Western Therapeutics Institute | 4.26B |